New hospital medicines, without price agreements, may be temporarily excluded from the basic package due to high prices. Zorginstituut advises on inclusion, and the minister negotiates prices with the manufacturer. Zorginstituut uses data from Medicines Horizon Scan to recommend medicines for the sluice, which is for high-cost treatments in medical-specialist care within hospitals.
These medicines are still in the approval process. These medicines are included in the sluice candidate letter.
| Active substance | Expected Registration | Indication |
|---|---|---|
| Wondermiddel | January 2024 | Breast cancer, advanced, HR+ en HER2-, 1L or 2L. Lorem ipsum dolor sit amet, consectetur adipiscing |
Medicines that are included in the sluice are subject to negotiation between the minister and the manufacturer. Once the medicine is out of the sluice, it is clear whether and at what price the medicine will be reimbursed.
These medicines were still in the sluice in the previous scan. Meanwhile, an agreement has been reached with the manufacturer, it is included in the basic insurance and is registered or reimbursed.